Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This study will address whether the additional use of Intravenous (IV) iron on top of
standard care will improve the outlook for patients with heart failure and iron deficiency.
One group of participants will receive treatment with iron injections and the other group
will not receive any iron injections.